Schedule 13G ownership disclosure

Evolent Health Inc

Class A Common Stock · CUSIP: 30050B101

Event date: 2025-11-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Rubicon Fund II LP

    Shares: 5,032,468.70 · Class: 4.51%

  • Rubicon Fund II PF LP

    Shares: 783,654.30 · Class: 0.7%

  • Rubicon OP GP II LP

    Shares: 5,816,123.00 · Class: 5.21%

  • Rubicon OP GP II LLC

    Shares: 5,816,123.00 · Class: 5.21%

  • Rubicon Founders LLC

    Shares: 5,816,123.00 · Class: 5.21%

  • Boehler Adam

    Shares: 5,816,123.00 · Class: 5.21%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950103-25-014793
Form type
SCHEDULE 13G
Filer
Boehler Adam
CIK
CIK 1982325
Filed
Nov 14, 2025
Reporting period
Nov 13, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub